Advertisement

Journal of Tongji Medical University

, Volume 19, Issue 4, pp 260–263 | Cite as

Multidrug resistance pglycoprotein function of bone marrow hematopoietic cells and the reversal agent effect

  • Chen Zhichao
  • Takeshita A. 
  • Zou Ping
  • Liu Zhongping
  • Kozaka M. 
  • You Yong
  • Song Shanjun
  • Ohnishi K. 
  • Ohno R. 
Article

Summary

The multidrug resistance P-glycoprotein (P-gp) expression and function in hematopoietic stem/progenitor cells were studied to investigate whether the inhibition of hematopoietic cell P-gp function by multidrug resistance reversal agent increases the cytotoxicity of chemotherapy drugs on the hematopoietic cells. The expression of P-gp on the surface of CD34 + cells from healthy human marrow was examined by flow cytometry. The multidrug resistance reversal agent MS209 was used to measure the effects of MS-209 on the Rhodamin-123 uptaking of CD34 + hematopoietic cells. By using methylcellulose semi-solid culture, normal human granulocyte-macrophage clonal formation unit (CFU-GM) was cultured. The changes in CFU-GM inhibitory rate caused by daunorubicin were determined in the presence or absence of MS-209. The results showed that the P-gp expression rate of bone marrow CD34 + cells was 13. 3 %. MS-209 obviously increased the Rhodamin-123 uptake of CD34 + positive cells. The mean inhibitory rate of daunorubicin for CFU-GM was 29. 6 %, but it was increased to 43. 3 % in the presence of MS-209 with the difference being significant (P<0. 05). It was concluded that hematopoietic cells expressed P-gp protein and possessed active function. MS-209 could inhibit the membrane efflux pump and increase the cytotoxicity of chemotherapy drugs to the clonal growth of hematopoeitic stem cells, suggesting the side effects of these drugs on the hematopoietic system should be taken into consideration in the clinical use.

Key words

hematopoietic stem cells P-glycoprotein multidrug resistance reversal agent 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thiebaut F, Tsuruo T, Hamada Het al. Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA, 1987, 84:7735PubMedCrossRefGoogle Scholar
  2. 2.
    Boesch D, Gaveriaux C, Jachez Bet al. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC833. Cancer Res, 1991, 51:4226PubMedGoogle Scholar
  3. 3.
    Tsuruo T. Mechanisms of multidrug resistance and implications for therapy. Jan J Cancer Res, 1988, 79:285Google Scholar
  4. 4.
    Tsuruo T, Lida H, Tsukagoshi Set al. Overcoming of vincristine resistance in P388 leukemia in vivo and vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res, 1981, 41:1967PubMedGoogle Scholar
  5. 5.
    Yano S, Sone S, Nishioka Yet al. Cyclosporin A enhances susceptibility of multidrug resistance human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes. Jan J Cancer Res, 1994:85(2):194Google Scholar
  6. 6.
    MS-209 1998, 184(5), 305Google Scholar
  7. 7.
    Arceci R, Horwity Croop Jet al. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA, 1988, 85:4350PubMedCrossRefGoogle Scholar
  8. 8.
    Tokeshita A, Shinjo K, Kozaka Met al. New flow cytometer method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and Streptavidin-RED670 conjugate. Jan Cancer Res, 1995, 86: 607Google Scholar

Copyright information

© Springer 1999

Authors and Affiliations

  • Chen Zhichao
    • 1
  • Takeshita A. 
    • 2
  • Zou Ping
    • 1
  • Liu Zhongping
    • 1
  • Kozaka M. 
    • 1
  • You Yong
    • 1
  • Song Shanjun
    • 1
  • Ohnishi K. 
    • 2
  • Ohno R. 
    • 1
  1. 1.Institute of HematologyTongji Medical UniversityWuhan
  2. 2.The Third Internal MedicineMedical UniversityJapan

Personalised recommendations